Human Reproductive Technologies Market - Forecasts to 2019 (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices)

DUBLIN, April 30, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/7kfzf7/human) have announced the addition of the "Human Reproductive Technologies Market - Global Industry Analysis, Size, Procedures, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

This report covers the market analysis for various drugs, devices and treatment technologies used in assistance and to control human reproduction. The stakeholders for this study include manufacturers and providers of contraceptive technologies and infertility solutions.

The market overview section of the report demonstrates the market dynamics and trends such as the drivers, restraints and opportunities that influence the current nature and future status of this field. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global human reproductive technologies market.

The global human reproductive technologies market is categorized on the basis of various infertility treatments and contraceptive technologies. The infertility technologies market is analyzed in this report with respect to drugs as well as types of treatment procedures. With respect to drugs, the report includes leading brands (by sales) from three major classes, namely, gonadotropins, androgens and erectile dysfunction. The drug brands analyzed in this study include Gonal-f, Follistim AQ, AndroGel, Testim, Viagra, Cialis and Levitra/Staxyn.

The market revenue and forecast for each brand has been provided for the period 2011 to 2019 in terms of USD million, along with the CAGR for the forecast period 2013 to 2019. The types of infertility treatment procedures studied in the report include in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), zygote intrafallopian transfer (ZIFT), gamete intrafallopian transfer (GIFT) and intrauterine insemination (IUI). This section provides the global number of procedures performed historically for 2011 and 2012 along with the forecast for the period 2013 to 2019.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Global Human Reproduction Technologies Market, by Infertility Treatment

Chapter 5 Global Human Reproductive Technologies Market, by Contraceptive Technologies

Chapter 6 Global Human Reproductive Technologies Market Revenue, by Geography

Chapter 7 Recommendations

Chapter 8 Company Profiles

Companies Mentioned: 

• Abbott Laboratories, Inc.
• Actavis, Inc.
• Bayer AG
• Church & Dwight, Co. Inc.
• Cook Medical, Inc.
• Ferring International Center S.A.
• Johnson & Johnson
• Merck & Co., Inc.
• Merck Serono
• Pfizer, Inc.
• Reckitt Benckiser Group plc
• Teva Pharmaceutical Industries Ltd.
• Warner Chilcott plc

For more information visit http://www.researchandmarkets.com/research/7kfzf7/human

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets